Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Interferon beta-1a in primary progressive MS: an exploratory, randomized, controlled trial.
Male Sex Is Independently Associated with Faster Disability Accumulation in Relapse-Onset MS but Not in Primary Progressive MS.
The age-range of risk of developing multiple sclerosis: evidence from a migrant population in Australia.
Topical Application of Fingolimod Perturbs Cutaneous Inflammation.
An observational comparison of natalizumab vs. fingolimod using JCV serology to determine therapy.
Optimizing parameter choice for FSL-Brain Extraction Tool (BET) on 3D T1-images in multiple sclerosis.
Central motor conduction time may predict response to fampridine in patients with multiple sclerosis.
New Analysis Suggests Aubagio® (teriflunomide) Slows Brain Atrophy in People with Relapsing Multiple Sclerosis
Vinpocetine inhibits oligodendroglial precursor cell differentiation.
A Randomized Placebo-Controlled, Crossover-Design Study of the Effects of Low Dose Naltrexone
Cyclophosphamide modulates CD4+ T cells into a T helper type 2 phenotype and reverses increased IFN-gamma production of CD8+ T cells in secondary progressive multiple sclerosis.
Cerebrospinal fluid biomarkers of β-amyloid metabolism in multiple sclerosis.
Early signs of memory impairment among multiple sclerosis patients with clinically isolated syndrome.
Multiple sclerosis: Spinal cord grey matter loss correlates with disability in MS.
Blockade of CD47 ameliorates autoimmune inflammation in CNS by suppressing IL-1-triggered infiltration of pathogenic Th17 cells.
Rituximab induces clonal expansion of IgG memory B-cells in patients with inflammatory central nervous system demyelination.
Review of subcutaneous interferon β-1a, delivered via the electronic self-injection device RebiSmart™, for the treatment of multiple sclerosis.
Sustained disease-activity-free status in patients with relapsing-remitting multiple sclerosis treated with cladribine tablets in the CLARITY study: a post-hoc and subgroup analysis.
DemTect, PANDA, EASY, and MUSIC: Cognitive Screening Tools with Age Correction and Weighting of Subtests According to Their Sensitivity and Specificity.
Lodonal/LDN
Drugs to be Discontinued
Interferon-β and serum 25-hydroxyvitamin D interact to modulate relapse risk in MS.
Mapi Pharma granted United States patent covering glatiramer depot for multiple sclerosis
Don't stress about it!: Is stress management a disease-modifying therapy for multiple sclerosis?
The environment and disease: association or causation?

Pages